Evidence map›Paper›PMID 30085047›Full record

ArticleThe Journal of infectious diseases2018

Reply to Darcis and Berkhout.

Ingeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, Marchina E van der Ende, Hanh T Pham, Thibault Mesplede, Suzan D Pas, Jolanda J C Voermans, Rob Schuurman, David A M C van de Vijver and 4 more

Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Journal of infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04453436 (HIV Drug Resistance Profiles Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04453436 active not recruitingnot on this mapstarted 2023, after this paper: background citation

HIV Drug Resistance Profiles Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil

Typeobservational_patient_registrySponsorFederal University of São PauloRan2023 to 2026Enrolled2,500ConditionsHIV, Drug, ResistanceArmsTenofovir Disoproxil
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ingeborg E A WijtingDepartment of Internal Medicine-Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands.
Cynthia LunguDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Bart J A RijndersDepartment of Internal Medicine-Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands.
Marchina E van der EndeDepartment of Internal Medicine-Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands.
Hanh T PhamMcGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Québec, Canada.
Thibault MespledeMcGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Québec, Canada.
Suzan D PasDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Jolanda J C VoermansDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Rob SchuurmanVirology, Department of Medical Microbiology, University Medical Center Utrecht, The Netherlands.
David A M C van de VijverDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Patrick H M BoersDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Rob A GrutersDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Charles A B BoucherDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Jeroen J A van KampenDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV-1HIV SeropositivityCandidaDolutegravirHeterocyclic Compounds, 3-RingHumansOxazinesPiperazinesPyridonesDolutegravirHeterocyclic Compounds, 3-RingOxazinesPiperazinesPyridones

Identifiers

PMID30085047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.